Pillstats
Rx only · Tablet · Oral

Norethindrone Acetate

Brands: Gallifrey · Norethindrone Acetate

6 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US6 NDCs
6 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
RxCUI (US)7514
US makers6 labelers
Packages7
DEA / ScheduleNone

US acquisition costNADAC · per unit

Average across 5 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.

$0.087$0.174$0.260$0.347Dec 2025Mar 2026Jul 2026
$0.293
Latest avg · Jul 22, 2026
-3%
Since Dec 17, 2025
6
Active US suppliers
43%
Top-2 supplier share*

Medicaid dispensing volumeSDUD · per quarter

Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.

38K75K113K150K2025 Q12025 Q22025 Q32025 Q42026 Q1
127K
Rx · 2026 Q1
6.7M
Units dispensed
+6%
Rx vs. year ago
5
Quarters · since 2025 Q1

Who makes it6 active · 0 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
Glenmark Pharmaceuticals Inc., USAunknown2SUPPLYING
Teva Pharmaceuticals USA, Inc.unknown1SUPPLYING
Golden State Medical Supply, Inc.unknown1SUPPLYING
Ingenus Pharmaceuticals, LLCunknown1SUPPLYING
American Health Packagingunknown1SUPPLYING
Xiromed, LLC.unknown1SUPPLYING

Regulatory & supply events

No recalls, shortages, or registration changes on record for this drug concept.